EP3524230
LYFJABLÖNDUR SEM INNIHALDA CCR3 MÓTLYF
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.4.2013EP published:
11.8.2021EP application number:
18213458.5
EP translation filed:
12.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
1.4.2033Expiry date:
1.4.2026Next due date:
30.4.2026
Title:
PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
Timeline
Today
2.4.2013EP application
11.8.2021EP Publication
12.11.2021Translation submitted
15.12.2021Registration published
1.4.2026Expires
Owner
Name:
Alkahest, Inc.Address:
125 Shoreway Road, Suite D, San Carlos, CA 94070, US
Inventor
Name:
FETSCHER, AlfredAddress:
55216 Ingelheim Am Rhein, DE
Name:
SCHER, Jochen MatthiasAddress:
55216 Ingelheim Am Rhein, DE
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
12163078Date:
4.4.2012Country:
EP
Classification
Categories:
A61K 9/00, A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/4545, A61K 9/16, A61P 1/04, A61P 17/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 13.4.2022
Expires: 1.4.2023
Payer: Patice ehf.
Number: 11
Paid: 22.4.2023
Expires: 1.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.4.2024
Expires: 1.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.4.2025
Expires: 1.4.2026
Payer: Árnason Faktor ehf.